Antiviral Properties of R. tanguticum Nanoparticles on Herpes Simplex Virus Type I In Vitro and In Vivo
In conclusion, we demonstrated that R. tanguticum nanoparticles could inhibit HSV-1 infection through multiple mechanisms. These results suggest that R. tanguticum nanoparticles may have novel roles in the treatment of HSV-1 infection.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Brain | China Health | Cold Sores | Complementary Medicine | Drugs & Pharmacology | Encephalitis | Genetics | Genital Herpes | Herbs | Herpes | Nanotechnology | Neurology | Study